Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $516.74 | 28 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $86.07 | 4 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $77.28 | 4 | $0 (2021) |
| ABBVIE INC. | $75.17 | 3 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $63.88 | 3 | $0 (2024) |
| Novo Nordisk Inc | $29.65 | 2 | $0 (2021) |
| Grifols USA, LLC | $21.09 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $18.59 | 1 | $0 (2024) |
| Amgen Inc. | $17.78 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $17.38 | 1 | $0 (2024) |
| Axsome Therapeutics, Inc. | $16.50 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $256.79 | 13 | ABBVIE INC. ($75.17) |
| 2023 | $62.34 | 3 | Janssen Pharmaceuticals, Inc ($48.93) |
| 2021 | $197.61 | 12 | SANOFI-AVENTIS U.S. LLC ($77.28) |
All Payment Transactions
28 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $33.69 | General |
| Category: NEUROSCIENCE | ||||||
| 10/06/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: Respiratory | ||||||
| 08/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug), HETLIOZ | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: SCHIZOPHRENIA | ||||||
| 07/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: NEUROSCIENCE | ||||||
| 06/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Neurology | ||||||
| 05/22/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: PSYCHIATRY | ||||||
| 04/10/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Psychology/Psychiatric | ||||||
| 02/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Neuroscience | ||||||
| 02/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Neuroscience | ||||||
| 12/06/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.81 | General |
| Category: Neuroscience | ||||||
| 09/27/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: Neuroscience | ||||||
| 06/30/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2021 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $11.63 | General |
| Category: DIABETES | ||||||
| 10/08/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Diabetes | ||||||
| 09/30/2021 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: Pulmonology | ||||||
| 06/10/2021 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: PENNSAID | ||||||
| 05/27/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 04/22/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Inflammation | ||||||
| 04/16/2021 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug), JANUVIA, STEGLATRO | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: NEUROSCIENCE | ||||||
| 03/25/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/25/2021 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 25 | 25 | $353.00 | $160.08 |
| 2022 | 2 | 52 | 52 | $1,299 | $794.41 |
| 2021 | 1 | 32 | 32 | $448.00 | $210.60 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 86580 | Skin test for tuberculosis | Office | 2023 | 25 | 25 | $353.00 | $160.08 | 45.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 15 | 15 | $750.00 | $522.88 | 69.7% |
| 86580 | Skin test for tuberculosis | Office | 2022 | 37 | 37 | $549.00 | $271.53 | 49.5% |
| 86580 | Skin test for tuberculosis | Office | 2021 | 32 | 32 | $448.00 | $210.60 | 47.0% |
About Ben Back, PA
Ben Back, PA is a Medical healthcare provider based in Hazard, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619942562.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ben Back, PA has received a total of $516.74 in payments from pharmaceutical and medical device companies, with $256.79 received in 2024. These payments were reported across 28 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($516.74).
As a Medicare-enrolled provider, Back has provided services to 109 Medicare beneficiaries, totaling 109 services with total Medicare billing of $1,165. Data is available for 3 years (2021–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Hazard, KY
- Active Since 02/22/2006
- Last Updated 05/13/2021
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1619942562
Products in Payments
- SPRAVATO (Drug) $86.07
- UBRELVY (Drug) $75.17
- SOLIQUA 100/33 (Biological) $53.39
- ABILIFY MAINTENA (Drug) $41.21
- Ozempic (Drug) $29.65
- CAPLYTA (Drug) $26.61
- TOUJEO (Biological) $23.89
- REXULTI (Drug) $22.67
- Prolastin-C Liquid (Biological) $21.09
- UZEDY (Drug) $18.59
- Otezla (Drug) $17.78
- AIRSUPRA (Drug) $17.38
- Auvelity (Drug) $16.50
- BELSOMRA (Drug) $15.88
- FANAPT (Drug) $14.93
- PENNSAID (Drug) $13.01
- GVOKE PFS (Drug) $11.63
- TRINTELLIX (Drug) $11.29
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.